Henrik Nittmar CEO

Roles

18.11.202517.02.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
17.02.2026Corline Biomedical AB Stockholm
Bought — open marketAcquisition
10,000SEK 14.54
SEK 145,400.00
18.11.2025Corline Biomedical AB Stockholm
Bought — open marketAcquisition
13,000SEK 17.80
SEK 231,400.00